News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Men with BRCA1 and BRCA2 gene mutations should get annual prostate cancer screening
Prostate cancer guidelines should change so that all men from the age of 40 with mutations in either the BRCA1 or BRCA2 gene are offered regular PSA testing to detect early signs of the disease, experts are urging.
New drug combination to tackle advanced prostate cancer
Up to two in five advanced prostate cancer patients could be treated with a combination of two targeted drugs, according to new research.
New research identifies a more accurate way of predicting which blood cancer patients will relapse early
Scientists have identified a more accurate way of predicting which patients with multiple myeloma, a type of blood cancer, are likely to relapse early following treatment.
Stress may increase cancer risk in people with inherited cancer genes
Suffering from psychological stress could further increase cancer risk in those already genetically predisposed to the disease, according to new research.
Two new fast-growing oncology companies join the Innovation Gateway at the London Cancer Hub
Two new oncology companies, Kindling Bio and Beckman Coulter, have been secured as tenants at the Innovation Gateway, a leading life sciences incubator at the heart of the London Cancer Hub.
Innovative dual treatment shows promise in tackling deadly cancer
A new study has revealed a promising therapeutic strategy for pancreatic cancer, offering new hope for people living with this disease.
Athena Swan Silver renewal recognises ICR’s continued progress in fostering an inclusive research culture
The Institute of Cancer Research has been granted an Athena Swan Silver Award for a further four years, in recognition of the ICR’s continued progress in embedding gender equality and fostering an inclusive research culture.
ICR Centre for Protein Degradation and NEOsphere Biotechnologies announce research collaboration to discover new molecular glue degrader therapeutics
ICR Centre for Protein Degradation and NEOsphere Biotechnologies announce research collaboration to discover new molecular glue degrader therapeutics.
.jpeg?sfvrsn=2b0f927_1 "Ovarian High Grade ovarian organoid proliferating (Green Ki67 staining)")
New alcohol-based solution cuts time and cost of organoid harvesting
A new study unveils a fast, low-cost solution for harvesting organoids – miniature three-dimensional (3D) models of human tissue – that could accelerate cancer research and make advanced cell culture techniques more widely accessible.
---945x532.jpg?sfvrsn=73000500_2 "radiotherapy IMRT (photo: Jan Chlebik/the ICR) - 945x532")
Cutting-edge proton beam therapy is no better than advanced radiotherapy for treating head and neck cancer
Cutting edge proton beam therapy is no better than intensity-modulated radiotherapy for treating people with head and neck cancer, according to new findings from a nationwide clinical trial.
Breakthrough discovery reveals new drug target to stop pancreatic cancer spreading
Scientists have discovered a key protein that could be targeted with a drug to treat the most common and aggressive form of pancreatic cancer.
ICR and Enamine announce new collaboration in fragment-based drug discovery
The Institute of Cancer Research and Enamine Ltd. have announced a new research collaboration aimed at broadening the tools available for researchers working in fragment-based drug discovery (FBDD).
